Assignee
NOUSCOM AG
CH·5 granted patents·4 pending applications·4 citations·filing 2018–2023
Top patents by PatentIndex Score
9 records- 0184US11912743B2Compositition and uses of teleost invariant chain to enhance T cell response to a vaccineNOUSCOM AG·Filed 2018·Granted Feb 27, 2024·3 cites·9 claims
- 0278US11643666B2Eukaryotic cell lineNOUSCOM AG·Filed 2018·Granted May 9, 2023·1 cites·13 claims
- 0356US2025115928A1Recombinant Orthopox Viral Vector Encoding Immunostimulatory Proteins for Cancer TreatmentNOUSCOM AG·Filed 2023·Application pending·0 cites
- 0453US12576143B2Teleost invariant chain cancer vaccineNOUSCOM AG·Filed 2019·Granted Mar 17, 2026·0 cites·9 claims
- 0552US11578109B2Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancersNOUSCOM AG·Filed 2018·Granted Feb 14, 2023·0 cites·8 claims
- 0650US2024269272A1Vaccine composition comprising encoded adjuvantNOUSCOM AG·Filed 2022·Application pending·0 cites
- 0747US2021379170A1Selection of cancer mutations for generation of a personalized cancer vaccineNOUSCOM AG·Filed 2019·Application pending·0 cites
- 0845US11098324B2Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereofNOUSCOM AG·Filed 2018·Granted Aug 24, 2021·0 cites·15 claims
- 0936US2020230220A1Neoantigen vaccine composition for treatment of cancerNOUSCOM AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOUSCOM AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →